Unresolved long-term risks and generalizability limitations: transcatheter vs aortic valve replacement from the RHEAI trial. Akhtar M, Naseer B, Sajid I. Eur Heart J 2026 Jun 5:ehag204. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Akhtar M, Naseer B, Sajid I. Unresolved long-term risks and generalizability limitations: transcatheter vs aortic valve replacement from the RHEAI trial. Eur Heart J 2026 Jun 5:ehag204. doi: 10.1093.
PMID: 42244331